Susan Hasty, Publisher
Table of Contents . . . July 15th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - High-dose interferon benefits hepatitis C patients infected with genotype 1
Hepatitis B Vaccine - Waiting to vaccinate against hepatitis B may be best policy for preterm infants
Hepatitis B Virus - Seroconversion is earlier in hepatitis B virus genotype B
Pathology - Inflammation before liver cancer surgery influences outcomes in hepatitis C
Carcinogenesis - Nerve growth factor may play some role in tumor vascularity
HCV Therapy - Schering-Plough commends NIH for consensus statement on management of HCV
Hepatitis C Therapy - Multiple dose clinical trials initiated of therapeutic monoclonal antibody
Hepatitis C Therapy - PEGASYS data support new disease management consensus reached by U.S. NIH
Legal Issues - State must pay for liver transplants, appeals court says
Patent Dispute - Triangle Pharmaceuticals announces final settlement of Coviracil patent dispute
Patents - Synergy Vaccines announces issuance of U.S. patent for SynerVax technology
Stock Offering - SciClone Pharmaceuticals completes direct offering of common stock
Transfusion Medicine - Preoperative recombinant erythropoietin cuts the need for pediatric transfusions
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.